Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Extension for Community Health Outcomes (ECHO) Diabetes Program

ClinicalTrials.gov ID: NCT06552923

Public ClinicalTrials.gov record NCT06552923. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The Project ECHO model is currently used in 180 countries to address chronic disease care through a provider empowerment, tele-education approach using a "hub" and "spoke" learning model. Few studies have rigorously evaluated the impact of the program on patient outcomes using randomized designs. This study evaluated implementation of an ECHO Diabetes program on patient-level, provider-level, and center-level outcomes in underserved populations receiving diabetes care from primary care providers. Participants: Twenty Federally Qualified Health Centers (FQHCs) and FQHC "look alikes" across CA and FL were recruited to participate as spokes in the ECHO Diabetes trial. A stepped-wedge trial design was used with randomized, phased-in intervention entry for participating health centers (or "spokes"). Interventions: Spokes were provided access to 6-months of tele-education sessions with continuing medical education credits, access to real-time support for complex medical decision making with hub subspecialty teams, and access to a diabetes support coach. Main outcomes and Measures: Participating FQHCs ("spokes") provided aggregate data including Healthcare Effectiveness Data and Information Set (HEDIS) reporting on the % of patients with HbA1c \>9%.

Study identification

NCT ID
NCT06552923
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
University of Florida
Other
Enrollment
32,796 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2021
Primary completion
Jun 29, 2022
Completion
Dec 30, 2023
Last update posted
Aug 13, 2024

2021 – 2023

United States locations

U.S. sites
17
U.S. states
2
U.S. cities
14
Facility City State ZIP Site status
CommuniCare Davis Family Health Center Davis California 95616
St Agnes Medical Center Fresno California 93720
La Clinica Multiple Locations California 94601
Santa Rosa Community Health Centers Multiple Locations California 95403
Shasta Community Health Centers Multiple Locations California 96001
Health Service Alliance Rancho Cucamonga California 91730
Hill Country Community Clinic Redding California 96001
CommuniCare Salud Family Health West Sacramento California 95605
CommuniCare Hansen Family Center Woodland California 95695
Premier Community Health Dade City Florida 33525
Community Health of South Florida (CHI) Homestead Florida 33190
Banyan Health Systems Miami Florida 33134
Borinquen Medical Center Miami Florida 33137
Orange Blossom Family Health Orlando Florida 32805
Evara Health System Pinellas Park Florida 33718
Tampa Family Health Center Tampa Florida 33610
Treasure Coast Community Health Vero Beach Florida 32960

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06552923, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 13, 2024 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06552923 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →